Mezigdomide (CC-92480) activates innate and adaptive immune populations in the bone marrow microenvironment of heavily pre-treated multiple myeloma patients
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
multiple myeloma patients,multiple myeloma,bone marrow microenvironment,adaptive immune populations,pre-treated
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要